Modern Healthcare January 17, 2023
Kaiser Health News: Darius Tahir

Controlled substances became a little less controlled during the pandemic. That benefited both patients (for their health) and telehealth startups (to make money).

Some potentially addictive medications — like buprenorphine and Adderall — are now far more available online to patients because of regulatory changes. Given the scarcity of qualified doctors to treat some of the behavioral health conditions associated with these drugs, like opioid use disorder or attention-deficit/hyperactivity disorder, doctors’ new ability to prescribe online or, in some cases, by telephone is a huge change. But easier access to the drugs has both upsides and downsides, since they’re often dispensed without accompanying therapy that improves the odds of a patient’s success.

Pre-pandemic, patients sometimes traveled several hours for addiction...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Mental Health, Provider, Regulations
‘Investors Are Hungry To Find the Best’: It’s Feast or Famine in Digital Behavioral Health Investing
ABA Provider NeurAbilities Healthcare’s CEO Katheleen Stengel Resigns
Therapeutic Relationship Plays Key Role in Psychedelic Treatment
CEO of KKR-Backed Autism Provider BlueSprig Steps Down
Research: More People Use Mental Health Benefits When They Hear That Colleagues Use Them Too

Share This Article